Anika Therapeutics, Inc.ANIKNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, structural decline.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$3.02M
↓ 88% below average
Average (9y)
$25.52M
Historical baseline
Range
High:$54.34M
Low:$-4.16M
CAGR
-27.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $3.02M | -79.9% |
| 2023 | $15.06M | -17.1% |
| 2022 | $18.16M | +536.2% |
| 2021 | $-4.16M | -314.6% |
| 2020 | $-1.00M | -102.5% |
| 2019 | $40.24M | +45.5% |
| 2018 | $27.66M | -44.7% |
| 2017 | $50.02M | -8.0% |
| 2016 | $54.34M | +4.7% |
| 2015 | $51.91M | - |